Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

International project develops heart device suited to Japanese market:

This article was originally published in Clinica

Executive Summary

Each year, 2,000-3,000 Japanese patients require artificial hearts, but are unable to acquire one due to the high cost and large size of conventional pumps, which are unsuitable for many Japanese people. Recently, the Tokyo Women's Medical University (in liaison with researchers from Waseda University, Sun Medical Technology Research and the US University of Pittsburgh) successfully implanted a small-sized blood pump, reports Asahi Shimbun. The Evaheart is 420 grams, which means it can be used in smaller women and children. The device costs around Y5m ($46,000), which is less than half the price of foreign pumps. It is hoped that the new pump will encourage more manufacturing of implant devices in Japan.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055575

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel